DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Furuta T, Shirai N. et al.
Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies.
Drug Metab Pharmacokinet 2005; 20: 153-167
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.